Abstract
It is well known that a too high challenge dose can overcome immunity so that it is impossible to find any difference between the control and immunized groups. Hence the so-called minimal dose must be determined for each tumour, i. e. the amount of viable tumour cells capable of growing in 100% of the control animals using a standard method of inoculation. This minimal dose shows great variations for different tumours and is influenced not only by the antigenicity of the tumour used, but also by its general biological properties. The degree of immunity achieved for different tumours is therefore best determined not by comparing the absolute number of cells overcoming immunity, but by the number of the minimal doses.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1969 Springer-Verlag Berlin · Heidelberg
About this chapter
Cite this chapter
Koldovský, P. (1969). Methods of Detection of Antitumour Immunity. In: Tumor Specific Transplantation Antigen. Recent Results in Cancer Research, vol 22. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-88536-5_2
Download citation
DOI: https://doi.org/10.1007/978-3-642-88536-5_2
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-88538-9
Online ISBN: 978-3-642-88536-5
eBook Packages: Springer Book Archive